Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission
This study has been completed.
Study NCT00213083   Information provided by Population Council

First Received on September 13, 2005.   Last Updated on May 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
AIDS
Sexually Transmitted Diseases
HIV Seroconversion
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Seropositivity
More general conditions related to this trial
Genital Diseases, Female
Genital Diseases, Male
Immune System Diseases
Immunologic Deficiency Syndromes
Infection
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Carraguard (PC-515)
Additional drug interventions recognized in this trial
Anti-Infective Agents
More general drug interventions related to this trial
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Population Council
United States Agency for International Development (USAID)
Bill and Melinda Gates Foundation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services